Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Over the past year the Immunotherapy Specialist Interest Group has been working on producing high quality information to support the use of subsequent line immunosupressants for patients with irAEs in whom steroids are not enough. The first four of these monographs are now available for the membership to access on the resources section of the Immunotherapy page on the BOPA website . More to follow later in the year.

The monographs are available on the resource section of the BOPA Immunotherapy Group section of the BOPA website. In addition, they are available on the Clinical Guidelines Section of the Immuno-Oncology Clinical Network website.

The monographs are also available via the useful website pages or directly from this link.

 

Latest News

By Suriya Marshall on 19th June 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations We’re pleased to launch the BOPA EDI Excellence Award, recognising individuals and teams who are actively advancing equity, diversity and inclusion in cancer pharmacy. This…

Read article
By Suriya Marshall on 19th June 2026

BOPA Above & Beyond Awards 2026

The Above and Beyond Award celebrates individuals and teams going over and above what is expected of them in the workplace. It is to celebrate those achievements of BOPA members…

Read article
By BOPA Executive Committee on 16th June 2026

BOPA Fellowship Nominations 2026 are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing…

Read article
By Pharmaceutical Press (PhP) on 15th June 2026

Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest: We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP). PhP is developing a new resource to support healthcare…

Read article